CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 266 filers reported holding CYTOKINETICS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,162 | +29.7% | 616,478 | +43.6% | 0.06% | +30.2% |
| Q2 2023 | $14,001 | -29.6% | 429,219 | -24.0% | 0.04% | -37.7% |
| Q1 2023 | $19,874 | -27.7% | 564,752 | -5.8% | 0.07% | -29.6% |
| Q4 2022 | $27,471 | -99.9% | 599,542 | -4.7% | 0.10% | -18.3% |
| Q3 2022 | $30,465,000 | +18.6% | 628,799 | -3.8% | 0.12% | +22.4% |
| Q2 2022 | $25,677,000 | -12.1% | 653,513 | -17.6% | 0.10% | -3.9% |
| Q1 2022 | $29,196,000 | -23.8% | 793,156 | -5.6% | 0.10% | -20.3% |
| Q4 2021 | $38,315,000 | +30.5% | 840,601 | +2.3% | 0.13% | +17.4% |
| Q3 2021 | $29,369,000 | +35.4% | 821,747 | -25.0% | 0.11% | +41.6% |
| Q2 2021 | $21,686,000 | +2.8% | 1,095,804 | +20.9% | 0.08% | -11.5% |
| Q1 2021 | $21,090,000 | +59.8% | 906,722 | +42.8% | 0.09% | +42.6% |
| Q4 2020 | $13,197,000 | – | 635,086 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,260,836 | $54,752,000 | 9.31% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 118,102 | $1,518,000 | 1.14% |
| FORTALEZA ASSET MANAGEMENT INC/ | 20,560 | $264,000 | 0.53% |
| TFS CAPITAL LLC | 95,987 | $1,233,000 | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 152,200 | $1,956,000 | 0.38% |
| Nine Chapters Capital Management LLC | 20,600 | $265,000 | 0.36% |
| Timpani Capital Management LLC | 67,551 | $868,000 | 0.35% |
| WASATCH ADVISORS LP | 1,492,698 | $19,181,000 | 0.28% |
| LANSDOWNE PARTNERS (UK) LLP | 2,321,865 | $29,836,000 | 0.26% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 208,781 | $2,682,000 | 0.19% |